28
Participants
Start Date
December 19, 2022
Primary Completion Date
August 20, 2024
Study Completion Date
December 4, 2024
Darolutamide(BAY1841788, Nubeqa)
tablet, oral
Enzalutamide
tablet, oral
Memorial Sloan Kettering Cancer Center New York - Main Campus, New York
Central Ohio Urology Group - Gahanna, Gahanna
Unio Specialty Care - Urology - Sherman Oaks, Sherman Oaks
Mass General Cancer Center, Boston
Beth Israel Deaconess Medical Center - Oncology, Boston
Lead Sponsor
Bayer
INDUSTRY